Texas A&M University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Texas A&M University sits in the top decile of US sponsors by registered trial count (#248 of 15,742 sponsors by registered trial count).
Texas A&M University: 95 sponsored US clinical trials, 22 recruiting.
Texas A&M University sponsors 95 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 66 completed. 2 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Protein Metabolism, with 3 trials.
Top-decile sponsor footprint
Texas A&M University ranks in the top decile of sponsors by registered trial count (#248 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
66 of 69 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
95 total, page 1 of 2
Harvesting Health: Advancing Nutrition and Wellness for Moms and Babies
NCT07659821
Menu to Meal (M2M) Menu Labeling Intervention Study
NCT07329452
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
NCT06726590
Anabolic Response to Beef vs Plant Protein in (Pre)Frail Older Adults Using a Novel Stable Isotope Pulse Method
NCT07254403
Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring
NCT07254364
Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial
NCT07079995
The Neighborhood & Health Study
NCT06950775
TREC@TAMU Cancer Prevention Registry and Repository
NCT06826014
IPGx PILOT Whole Genome Sequencing Extension Cohort
NCT06766071
Virtual Walking Therapy for Neuropathic Pain Following Incomplete Spinal Cord Injury
NCT06330181
Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD
NCT05959434
Lutein, Zeaxathin, and Fish Oil Supplementation
NCT06489873
Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein
NCT06628349
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
NCT06480201
Evaluation of Biomarkers for Predicting Macronutrient Intake
NCT06582381
Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments
NCT05867433
The Use of a Non-Incised Minimally Invasive Flap Procedure in Conjunction With Emdogain® MI Compared to Traditional SRCP
NCT05964699
Prandial Metabolic Phenotype in Adults
NCT05400733
Metabolic and Functional Consequences of Aging in Health and Disease
NCT05240885
The Texas Interprofessional Pharmacogenomics (IPGx)
NCT06219720
Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury
NCT05005026
Improving Sleep Quality During Pregnancy Using an Oral Appliance
NCT03646214
Effectiveness of Scaling and Root Planing in Deeper Pockets
NCT06890689
Wearables and Cardiac Rehabilitation
NCT06065319
Investigating Behavior Change Methods for the Management of Hypertension
NCT07631546
The Change Club Study: Evaluation of Civic Engagement for Built Environment Change and Health Improvement
NCT05002660
Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore?
NCT06797089
Optimizing the Impact of the Healthy School Recognized Campus Program on Youth's CVD Risk Factors
NCT05977959
Produce Prescription for Healthy Blood Pressure
NCT07648758
E4D Compare Adapted to Preclinical Endodontics
NCT06567236
Evaluation of the Strong Hearts Urban Program
NCT06567184
Comparison of a Telehealth Versus In-person Intervention for Binge Eating
NCT05725408
Counterfactual Strategies, Physical Activity, and Wearable Trackers
NCT05192226
Alcohol PBS and Thinking About the Past
NCT05208593
Persistent Readiness Through Early Prediction Immunization Study
NCT05346302
An Interactive Mobile Health (mHealth) App as Intervention for High Anxiety and Depression in College Students
NCT07017569
Models of Nutrition From Continuous Glucose Monitors
NCT04991142
Impact of a Mobile App on Pregnant Women's Prenatal Genetic Testing Decision-making
NCT05055700
COPD Circuit Exercise
NCT05395390
Fiber Metabolism in Chronic Obstructive Pulmonary Disease
NCT04459156
BCG Vaccine for Health Care Workers as Defense Against COVID 19
NCT04348370
Anderson Study 1 - Tart Cherry Study
NCT04837274
Nutrition21 Study 1
NCT04828278
Cherries Role in Gut Microbiota-liver-brain Function
NCT05586386
Nutrition, Vision, and Cognition in Sport Study: Beef
NCT04427852
OA Therapy for Mouth-breathers Who Snore
NCT04876625
Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes
NCT04461236
Impact of Beef's Unique Food Matrix on Human Health
NCT04841460
Testing New Models of Diabetes Self-Management to Improve Population Health
NCT06370494
Effect of Oral Appliance Therapy on Atrial Fibrillation
NCT03835429
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Texas A&M University pipeline
22 recruiting of 95 indexed (23% open); 66 completed (69%).
Phase mix: 2 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Protein Metabolism (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Texas A&M University: open-pipeline peers nationwide
Peers matched on 95 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Texas A&M University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 95 trials (± recruiting share)
- AdventHealth · 95 trials · 17% recruiting
- Masimo Corporation · 96 trials · 3% recruiting
- University of Mississippi Medical Center · 96 trials · 10% recruiting
- University of Tennessee · 96 trials · 13% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Texas A&M University page
95 registered trials is a research-attention snapshot, not an endorsement of Texas A&M University or any single study.
- 22 of Texas A&M University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Protein Metabolism is the condition Texas A&M University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Protein Metabolism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Texas A&M University pipeline card: 95 registered trials from official public datasets.Report a data error.